FDA Approved Products
6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
DEPO-TESTADIOL
estradiol cypionate; testosterone cypionate
LOE Approaching
Pfizer
INJECTION · INJECTABLE
the treatment of: 1
1980
NDA30/100
DEPOCYT
cytarabine
LOE Approaching
INJECTION · INJECTABLE, LIPOSOMAL
newly diagnosed therapy-related acute myeloid leukemia (t-AML)AML with myelodysplasia-related changes (AML-MRC) in adults+2
1999
NDA30/100
DEPODUR
morphine sulfate
LOE Approaching
EPIDURAL · INJECTABLE, LIPOSOMAL
2004
NDA30/100
DERMA-SMOOTHE/FS
fluocinolone acetonide
LOE Approaching
TOPICAL · OIL
1988
NDA30/100
DERMATOP
prednicarbate
LOE Approaching
Bausch + Lomb
TOPICAL · OINTMENT
1991
NDA30/100
DERMATOP E EMOLLIENT
prednicarbate
LOE Approaching
Bausch + Lomb
TOPICAL · CREAM
1993
NDA30/100
DERMOTIC
fluocinolone acetonide
LOE Approaching
OTIC · OIL/DROPS
1988
NDA30/100
DESFERAL
deferoxamine mesylate
LOE Approaching
INJECTION · INJECTABLE
1968
NDA30/100
DESMODA
desmopressin acetate oral solution
Launch
ORAL · SOLUTION
nephrogenic diabetes insipiduscentral diabetes insipidus
2026
NDA30/100
DESMOPRESSIN ACETATE
desmopressin acetate
LOE Approaching
Ferring Pharmaceuticals
ORAL · TABLET
nephrogenic diabetes insipiduscentral diabetes insipidus
2008
NDA30/100
DESOGEN
desogestrel; ethinyl estradiol
LOE Approaching
Merck & Co.
ORAL-21 · TABLET
pregnancy in women
1992
NDA30/100
DESONATE
desonide
LOE Approaching
Leo Pharma
TOPICAL · GEL
atopic dermatitis
2006
NDA30/100
DESONIDE
desonide 0.05%
LOE Approaching
Design Pharmaceuticals
TOPICAL · CREAM
1972
NDA30/100
DESONIDE
desonide
LOE Approaching
Design Pharmaceuticals
TOPICAL · OINTMENT
1974
NDA30/100
DESOWEN
desonide
LOE Approaching
Galderma
TOPICAL · CREAM
1984
NDA30/100
DESOXYN
methamphetamine hydrochloride
LOE Approaching
ORAL · TABLET, EXTENDED RELEASE
Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients 6 years of ageolder
1943
NDA30/100
DESVENLAFAXINE
desvenlafaxine fumarate
Peak
Fosun Pharma
ORAL · TABLET, EXTENDED RELEASE
2014
NDA30/100
DESVENLAFAXINE
desvenlafaxine fumarate
Peak
Teva
ORAL · TABLET, EXTENDED RELEASE
2013
NDA30/100
DESVENLAFAXINE
desvenlafaxine
Peak
ORAL · TABLET, EXTENDED RELEASE
2013
NDA30/100
DETROL
tolterodine tartrate
LOE Approaching
Viatris (2)
ORAL · TABLET
overactive bladder with symptoms of urge urinary incontinenceurgency+1
1998
NDA30/100
DETROL LA
tolterodine tartrate
LOE Approaching
Viatris (2)
ORAL · CAPSULE, EXTENDED RELEASE
overactive bladder with symptoms of urge urinary incontinenceurgency+1
2000
NDA30/100
DEXACORT
dexamethasone sodium phosphate
LOE Approaching
UCB Pharma
NASAL · AEROSOL
Rheumatoid arthritispsoriasis+9
1965
NDA30/100
DEXACORT
dexamethasone sodium phosphate
LOE Approaching
UCB Pharma
INHALATION · AEROSOL, METERED
Rheumatoid arthritispsoriasis+9
1962
NDA30/100
DEXEDRINE SPANSULE
dextroamphetamine sulfate
LOE Approaching
ORAL · CAPSULE, EXTENDED RELEASE
1976
NDA30/100